1. 931TiPPRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. (23rd October 2018) Authors: Collinson, F; Brown, S; Buckley, H; Ainsworth, G; Howard, H; Poad, H; Carr, G; Banks, R E; Brown, J; Velikova, G; Larkin, J; Nathan, P; Powles, T B; Vasudev, N S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Developing a digital data collection platform to measure the prevalence of sepsis in Wales. (19th April 2016) Authors: Sharif, B; Lundin, RM; Morgan, P; Hall, JE; Dhadda, A; Mann, C; Donoghue, D; Brownlow, E; Hill, F; Carr, G; Turley, H; Hassall, J; Atkinson, M; Jones, M; Martin, R; Rollason, S; Ibrahim, Y; Kopczynska, M; Szakmany, T Journal: Journal of the American Medical Informatics Association Issue: Volume 23:Number 6(2016:Nov.) Page Start: 1185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗